Western Wealth Management LLC Purchases 2,059 Shares of GE HealthCare Technologies Inc. $GEHC

Western Wealth Management LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 67.4% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,115 shares of the company’s stock after buying an additional 2,059 shares during the quarter. Western Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $379,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Lineweaver Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth $592,000. Exome Asset Management LLC purchased a new stake in GE HealthCare Technologies in the first quarter worth about $2,050,000. Nvwm LLC grew its holdings in GE HealthCare Technologies by 5,483.1% during the 2nd quarter. Nvwm LLC now owns 14,237 shares of the company’s stock worth $1,055,000 after acquiring an additional 13,982 shares in the last quarter. Galvin Gaustad & Stein LLC increased its position in GE HealthCare Technologies by 7.3% during the 2nd quarter. Galvin Gaustad & Stein LLC now owns 177,929 shares of the company’s stock valued at $13,179,000 after purchasing an additional 12,141 shares during the period. Finally, Andra AP fonden raised its holdings in shares of GE HealthCare Technologies by 104.9% in the 2nd quarter. Andra AP fonden now owns 59,000 shares of the company’s stock valued at $4,370,000 after purchasing an additional 30,200 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. BTIG Research set a $87.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday, October 29th. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their target price for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Evercore ISI boosted their price target on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Finally, Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $71.02 on Wednesday. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a market cap of $32.35 billion, a PE ratio of 14.67, a P/E/G ratio of 2.65 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a fifty day moving average price of $74.84 and a 200-day moving average price of $73.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same period in the prior year, the company posted $1.14 EPS. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.